WebJan 4, 2024 · Manufacturer: CSL Behring LLC Indication: HEMGENIX is an adeno-associated virus vector-based gene therapy indicated for the treatment of adults with Hemophilia B (congenital Factor IX deficiency) who: WebFeb 1, 2024 · Filing 2 CIVIL COVER SHEET filed..(Eisenhower, Brian) February 1, 2024: Filing 1 COMPLAINT against Khne + Nagel Management AG, Kuehne + Nagel Inc.. (Filing Fee $ 402.00, Receipt Number ANYSDC-27280056)Document filed by CSL Behring AG, CSL Behring L.L.C., Affiliated FM Insurance Company..(Eisenhower, Brian)
Worldwide Locations - CSL
WebCSL Behring 123,796 followers on LinkedIn. Biotherapies & Rare Disease CSL Behring, a Business Unit of CSL, is a global biotherapeutics leader driven by its promise to save lives. Focused on ... WebCSL.com CSL Calendar 2024 Key Dates 19 August Annual profi t and fi nal (ABN 99 051 588 348) will be held online on dividend announcement 10 September Shares traded ex-dividend 11 September Record date for fi nal dividend 9 October Final dividend paid 14 October Annual General Meeting 31 December Half Year ends 2024 Key Dates chuck e cheese\u0027s building
SEC.gov Filings & Forms - EDGAR
WebCSL Behring is a global leader in developing and delivering high-quality medicines that treat people with rare and serious diseases. Our treatments offer promise for people in more than 100 countries living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. Our Products WebCSL Behring has locations to serve patients around the globe. Please find all contact information below. Headquarters CSL Behring Corporate Headquarters phone: +1 610-878-4000 fax: +1 610-878-4009 1020 First Avenue PO Box 61501 King of Prussia, PA 19406-0901 USA Regional Sales Offices R&D and Manufacturing Locations WebFinancial Calendar CSL Limited. Investors > Financial Calendar. Filter by Year: 2024 2024 2024 2024. 14 Feb 2024 Time: 11:00 to 12:00. chuck e. cheese\u0027s commercial hammock 2002